Contraceptive Implants Are Driving Big Gains in Access to Family Planning
What have we achieved on the road to making universal access to family planning a reality? And what's next?
A pediatrician and renowned public health physician, Dr. Roy Jacobstein's work in reproductive health, family planning, child health, and public health services in low-resource settings spans over 30 years—from Washington DC, to Indo-Chinese refugee camps, to countries across Africa and Asia.
He served as an expert technical advisor at the World Health Organization (WHO), where he has been a key contributor to developing and updating WHO’s central guidance documents, Medical Eligibility Criteria for Contraceptive Use and Family Planning: A Global Handbook for Providers.
Jacobstein has also been a consultant for the U.S. Agency for International Development, the Gates Institute at the Johns Hopkins Bloomberg School of Public Health, the World Bank, and Save the Children. His peer-reviewed papers address many topics including unmet need for family planning, long-acting reversible and permanent contraceptive methods, the fragility of sub-Saharan African health systems, and fostering change among providers in medical settings. Before joining IntraHealth, Jacobstein served for over a decade as chief of the Communication, Management, and Training Division in the Office of Population at the U.S. Agency for International Development, as well as EngenderHealth’s medical director and clinical director of the ACQUIRE and RESPOND Projects. He is also an adjunct professor in the Department of Maternal and Child Health at the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill.
What have we achieved on the road to making universal access to family planning a reality? And what's next?
When it comes to who’s using contraception, we aren’t even close to 50-50.
The U.S. contribution to family planning programs represents less than one cheeseburger per American per year. We can do better.
The unavailability of vasectomy services in low-income countries is a program issue and a gender issue. Here's how we can address it.
The SDG indicators will guide us to progress. But is one missing?
Vasectomy is safe, effective, and leads to greater gender equity. So why hasn’t it caught on in many low-income countries?
For less than the cost of a cheeseburger per American per year, we could reduce population growth by 500 million. What's the holdup?
Health workers don't arrive at work as blank slates. They bring their own multidimensional personalities, beliefs, and biases.
IntraHealth's INSPiRE project is designed to catalyze a model of integrated service delivery—and associated performance indicators—into national policy and practice in francophone West Africa. This...
A Qualitative Study of Vasectomy Users, Providers, and Stakeholders in Four Counties
Vasectomy use is plagued by low demand among men. Nevertheless, its compelling advantages make substantial investment worthwhile. On the supply side, a priority is to actively link vasectomy with...
This presentation provides an overview of vasectomy as a family planning method and was presented at the Long-Acting and Permanent Methods Community of Practice Meeting on Vasectomy in Washington DC...